Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Another step forward for gene therapy to treat hearing loss

      Researchers from Harvard Medical School in the US have recently used gene therapy to restore hearing in mice with a particular type of Usher syndrome. Carina Santos, our Translational Research Manager, tells us more about the work, and what it means for using gene therapy to treat hearing loss in people in the future.

      By: Carina Santos | 14 June 2017

      Genes are the master regulators of the characteristics that make us human, from the colour of our eyes to the number of toes we have in each foot, and our hearing is no exception!

      Over half of the cases of hearing loss in children worldwide are due to errors in genes called mutations. In fact, hearing loss acquired during ageing can also be influenced by our genetic make-up. Scientists around the world are working hard to develop gene therapies to correct the mutations that cause hearing loss. Two recent advances made by researchers at Harvard Medical School in the US have brought the prospect of gene therapies for hearing loss closer.

      Delivering genes to the cochlea (inner ear)

      The cochlea is the “hearing” part of the ear, where the sensory hair cells are located. These cells are responsible for translating sound into electrical signals that are sent to the brain, allowing us to hear. So, genetic mutations that affect the way these cells develop or work are likely to cause hearing loss. Scientists working on gene therapy to correct gene mutations in hair cells face the substantial challenge of how to deliver corrected genes to the large number of sensory hair cells in the cochlea, which is hard to access, as it is hidden behind the mastoid bone in our skull, the hardest bone in the body.

      The research, published this month in the scientific journal Nature Biotechnology, presents a new and highly efficient method of delivering corrected genes to 80-90% of sensory hair cells, using a new viral vector called Anc80L65. A viral vector is a harmless virus that scientists engineer to infect specific cells and deliver genes into them. Anc80L65 surpasses existing vectors because its high efficiency allows delivery of genes to different types of hair cells (called inner and outer hair cells), which have complementary and essential roles in the hearing process, as well as vestibular hair cells, which control balance and spatial orientation.

      How gene therapy restored hearing and balance in a mouse model

      Usher syndrome is a genetic disorder that causes profound deafness, blindness and balance disorders. It is responsible for 3-6% of childhood deafness. In a specific type of Usher syndrome, called type 1c, a gene called USH1C is defective, which results in hair cells failing to develop correctly, showing disorganised hair bundles (the hair-like structures on top of the cells that sense sound, and that give hair cells their name), and then dying. In this study, the researchers used mice which have the same mutation in their version of the USH1C gene, which is called Ush1c (naming conventions for genes mean that mouse genes are in lower case, while human genes are capitalised).

      By introducing a corrected version of the Ush1c gene into the inner ear of newborn mice, using the Anc80L65 vector, the researchers were able to restore the correct organization of the hair bundles and improve hearing in the mice by over a thousand-fold, relative to other existing inner ear gene therapy approaches. Along with hearing, balance was also restored in these mice. Although it’s still early days, gene therapy shows promise as a treatment to restore hearing and studies like these are helping to speed up access to these therapies by people.

      What’s next?

      The researchers are now focussed on perfecting the Anc80L65 vector, to limit the delivery of genes to hair cells only. Moreover, although the therapy showed the highest efficiency when used in newborn mice, the best therapeutic window for humans is still to be determined. Unlike in mice, human hearing is fully developed before birth and researchers need to assess if gene therapy would have to be given pre-natally, which would be a significant challenge, or if it will work if administered after birth.

      Find out more

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      This research was published in the journal Nature Biotechnology.

      Full references:

      Pan B, Askew C, Galvin A, Heman-Ackah S, Asai Y, Indzhykulian AA, Jodelka FM, Hastings ML, Lentz JJ, Vandenberghe LH, Holt JR and Geleoc GS. Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c. Nat Biotechnol. 2017 Mar; 35(3):264-272.

      Landegger LD, Pan B, Askew C, Wassmer SJ, Gluck SD, Galvin A, Taylor R, Forge A, Stankovic KM, Holt JR, Vandenberghe LH. A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat Biotechnol. 2017 Mar; 35(3):280-284.

      You can find out more about our students, and the research we’re funding, in our biomedical research section.

      If you’re interested in finding out more about our research, sign up to receive our Soundbite e-newsletter. It’s a monthly email, filled with the latest news about hearing and tinnitus research.

      Recent Posts

      Scientifically speaking...

      We funded Dr Helen Willis’s PhD research assessing ‘listening effort’ for people using a cochlear implant. It’s a subject close to Helen’s heart, as she’s an implant user.

      By: Dr Helen Willis
      13 December 2018

      A Christmas story of travelling with hearing loss

      The Deaf Traveller tells his tale of travelling with hearing loss to get home for Christmas on a train that he’s not sure where it is going. This is because the train does not have the right deaf awareness or effective communication tools for the 1 in 6 people in the UK with some form of hearing loss. Luckily, a Christmas miracle soon appears to ensure he has a stress-free journey home.

      By: Edward Rex
      12 December 2018

      Tribute to Professor Maria Bitner-Glindzicz

      Professor Maria Bitner-Glindzicz, a world-leading clinical geneticist at UCL, whose work helped families to understand the causes of their hearing loss, tragically died following an accident in September. As a tribute to her, we reflect on her contribution to hearing research.

      By: Action on Hearing Loss
      12 December 2018

      Regenerating hair cells – another piece of the puzzle

      Hair cells are crucial for our ability to hear, but we still don’t know exactly how they develop in the inner ear, or all the genes and processes that combine to make sure they work correctly. New research that we funded has shed light on how one particular gene is involved – Tracey Pollard from our research team explains more.

      By: Tracey Pollard
      11 December 2018

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.